Bridgeway Capital Management, LLC Geron Corp Transaction History

Bridgeway Capital Management, LLC

  • $4.24 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$1.05 - $2.18 $275,310 - $571,596
-262,200 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$1.01 - $1.83 $252,500 - $457,500
250,000 Added 2049.18%
262,200 $435,000
Q1 2018

May 15, 2018
BUY
$1.81 - $5.98 $22,082 - $72,956
12,200 New
12,200 $52,000

Others Institutions Holding GERN

# of Institutions
306
Shares Held
465M
Call Options Held
1.07M
Put Options Held
648K
View Full List

About GERON CORP

GERN Quotes by TradingView
  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $971M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email